Need for optimized dosages in the design of comparative clinical trials of anti-malarial drugs

We read with interest the publication on malaria treatment by Obonyo et al. (Malaria J 21:30, 2022). This commentary questions the methodology, especially the chosen time points of treatment outcome measures.

Automated summary

This commentary raises questions about the methodology of Obonyo et al.'s malaria treatment study, particularly regarding the chosen time points for measuring treatment outcomes.